The markets opened flat with Dow adding 5 points to 16,015 after a record close yesterday. Nasdaq rose 14 points to 3983.
On the upside
The European Medicines Association will continue to allow ARIAD Pharmaceuticals' (Nasdaq: ARIA) Iclusig to be used in patients with some added recommendations.
Pandora Media (NYSE: P) fell to a loss for the third quarter but revenue soared to beat analyst expectations.
The European Medicines Agency granted New Active Substance designation to Biogen Idec's (Nasdaq: BIIB) multiple sclerosis treatment Tecfidera.
On the downside
Violin Memory (NYSE: VMEM) widened third quarter losses more than expected and forecast current quarter revenue below estimates.
dELia*s (Nasdaq: DLIA) widened losses for the third quarter as revenue fell.
Third quarter earnings edged up for The Fresh Market (Nasdaq: TFM) but the results missed expectations prompting a downgrade.
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 added 2 points to 1797.